Search Results

Stemtech Corporation is proud to announce that it is on track to achieve the CEO and Chairman’s goal of becoming cash flow positive.

Stemtech Corporation announces a significant milestone in its global expansion strategy with the signing of a license Agreement with an established direct sales company, based in Kenya.

Stemtech is pleased to announce the engagement of Mr. I. Tufan Obuz, CPA, who has joined Stemtech Corporation in the newly created position of Chief Administrative Officer (CAO), reporting to the President & COO.

STEMTECH CORPORATION - (OTCQB:STEK) today announced the appointment of Mr. Claude Ayache as Vice President of Finance for Stemtech HealthSciences Corp, the US subsidiary.

STEMTECH CORPORATION announces Business Academies for their Independent Business Partners will be conducted in Mexico in May, the United States in June and Taiwan in October.

Charles S. Arnold, Chairman and CEO of Stemtech, stated “in addition to the May 23rd announced Debt Restructuring from our institutional investors over the last month, the company requested that current debt obligations outstanding to myself, as well as board members, management and professional trade creditors convert all their existing debt with the company to equity at the current market.

Stemtech Corporation (OTCQB:STEK) today announced that Life Factor Research, the Research and Development Division of Stemtech, has acquired its first contract to produce a while label product for a new client.

STEMTECH CORPORATION announces that Darryl V. Green, Board Director, Investor and Advisor, will be participating at the RHK Capital Disruptive Growth Conference in New York City.

Stemtech Corporation thanks Ray C. Carter, Jr. for his 15 years of service and commitment to the Company as Founder and CEO